Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR). - Wikidata - awgldk - TriplyDB

Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR).

Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR).

http://www.wikidata.org/entity/Q36557314

about

Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: a meta-analysis Administration of DHEA augments progesterone production in a woman with low ovarian reserve being transplanted with cryopreserved ovarian tissue.Basal serum testosterone levels correlate with ovarian response but do not predict pregnancy outcome in non-PCOS women undergoing IVF.The "graying" of infertility services: an impending revolution nobody is ready for.How the FMR1 gene became relevant to female fertility and reproductive medicine.Impact of dehydroepiandrosterone on clinical outcome in poor responders: A pilot study in women undergoing in vitro fertilization, using bologna criteria.Some aspects of interactivity between endocrine and immune systems required for successful reproduction.Is there an androgen level threshold for aneuploidy risk in infertile women?Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome.Diminished ovarian reserve, premature ovarian failure, poor ovarian responder--a plea for universal definitions.The importance of adrenal hypoandrogenism in infertile women with low functional ovarian reserve: a case study of associated adrenal insufficiency.Is androgen production in association with immune system activation potential evidence for existence of a functional adrenal/ovarian autoimmune system in women?Androgens regulate ovarian follicular development by increasing follicle stimulating hormone receptor and microRNA-125b expression.Genetics of androgen metabolism in women with infertility and hypoandrogenism.The impact of FMR1 gene mutations on human reproduction and development: a systematic review.Age-Specific IVF Outcomes in Infertile Women With Baseline FSH Levels ≥20 mIU/mL.Hypoandrogenism in association with diminished functional ovarian reserve.A double-blind randomised controlled trial on the effect of dehydroepiandrosterone on ovarian reserve markers, ovarian response and number of oocytes in anticipated normal ovarian responders.Dehydroepiandrosterone enhances decidualization in women of advanced reproductive age.

P2860

Q24187619-DF7BE40C-D9D4-4D9F-979A-60BAF2855F1A Q27028043-BA12249A-2F95-4818-ABC5-6CE618A4420D Q33722026-1A11A2B0-C279-473E-BC26-D1FC182AC048 Q33897193-33FBFF85-64D7-4F9F-9A4E-5A388E12083A Q33929556-736F2E37-FE8D-45C1-97D6-6F66B88B8271 Q34106386-4F075138-DE00-41D1-953E-8E7F88E2E80A Q34500280-C7BBF1C3-50C9-493D-8158-00B182B7F641 Q35441643-F561B8D5-5C54-4AE4-845E-139BC3AF96D4 Q35626377-A03D3E12-1D34-4C2E-89BC-0EB9CDB9A7C2 Q35834587-FC7CB16A-B618-4B93-9233-343895D377FE Q36378508-A6CFCCC0-6431-413A-A988-DD5DC8A25C3C Q36836870-AC28A88E-0524-4870-A89B-23860EE43294 Q36980751-BA118F00-E32B-49D9-BCEE-A541D5E795CC Q37612603-523766B8-0D87-45CF-82BA-13C9D401D332 Q38460006-EB083A68-5115-40D7-A2E7-C3D1E38D21E5 Q38901729-8897E5E9-8833-4C01-BC3A-25A90DF77360 Q48527505-83362A11-F563-4672-8674-4E16CF314978 Q48529490-2C6D88FC-0CC7-4A48-A887-D20E9D18E2D4 Q48562065-533B65F8-E60C-413B-BB72-24AE9E2D52B5 Q49346385-1317C665-B66D-4B8C-A198-CFB8D6387FE4

P2860

Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR).

http://www.wikidata.org/entity/Q36557314

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Starting and resulting testost ...... inished ovarian reserve (DOR).

@ast

Starting and resulting testost ...... inished ovarian reserve (DOR).

@en

type

label

Starting and resulting testost ...... inished ovarian reserve (DOR).

@ast

Starting and resulting testost ...... inished ovarian reserve (DOR).

@en

prefLabel

Starting and resulting testost ...... inished ovarian reserve (DOR).

@ast

Starting and resulting testost ...... inished ovarian reserve (DOR).

@en

P1433

Q36557314-5E7B62BF-6702-4644-8AA2-5F0F9662776C

P1476

Q36557314-AE6DF485-D18E-42B4-BD7E-591DD2AA4744

P2093

Q36557314-0EC97F8C-C21F-41B0-9F26-32A0D86F1C8B

Q36557314-1F5A4A25-7FCC-44B2-A4C5-C5FA78ECE790

Q36557314-2C041A19-0856-4106-B499-5F8D6E1411A2

Q36557314-3279E9A4-6B7D-4BFA-A188-074C06FACFF1

Q36557314-B3BD9273-3370-4455-B9C8-FFFE47753319

Q36557314-CECE8F62-3E91-4660-9CE0-CEEEB974397A

Q36557314-EC4FE6A2-ED2D-478A-8605-4175C841E327

P2860

Q36557314-165D4B33-2895-4A53-A13E-3D2DD87098F1

Q36557314-25EA10EE-7B92-4F53-9413-EC7FB4E40CB1

Q36557314-3AB246BE-EAC2-4FDC-8358-30D7A610B0E4

Q36557314-4341E52B-5A6B-48B0-B3EA-C15DF0BB2940

Q36557314-58B329D1-EFDC-42D6-B1D0-1E5418E06A58

Q36557314-6FF17EFC-D3C9-4D6F-AF7B-F6BDBB6F8E30

Q36557314-71D04CE9-DB21-49F0-80A3-F2932E7C75A8

Q36557314-7445ED4E-F679-4560-A6E1-03F0F7436FFB

Q36557314-7AB658BF-5CAF-42D2-88EC-EDC36BEF3D69

Q36557314-7F3C8717-7E80-40A3-BD6D-FCC667A6DF0B

P2888

Q36557314-785CF278-4EDD-4D21-9AA0-55447C3F2FE8

P304

Q36557314-D86946F3-247B-49DD-917E-98B001B5B8E0

P31

Q36557314-2DD277F7-4A3A-417D-8E5F-815AC0D7C182

P356

Q36557314-DDF09E47-A57A-4EEF-A2FE-B7177363EC0B

P433

Q36557314-C4973082-BC56-4F14-8F05-E5121F579347

P478

Q36557314-5E88C875-8203-4EF8-BD5E-B04BFC7A2BBA

P577

Q36557314-B4965390-A60E-43EE-AB03-072AFFB43321

P698

Q36557314-04CC6433-E60F-48F7-B099-13053ACDE7DF

P921

Q36557314-023AC1CD-F334-4868-91AF-32E643DA1CC2

P932

Q36557314-D7AF864B-0FE6-40CA-A0DB-18AC46FCA7C9

P356

S10815-012-9890-Z

P1433

Journal of Assisted Reproduction and Genetics

P1476

Starting and resulting testost ...... inished ovarian reserve (DOR).

@en

P2093

Andrea Weghofer

http://www.w3.org/2001/XMLSchema#string

Ann Kim

http://www.w3.org/2001/XMLSchema#string

Aya Shohat-Tal

http://www.w3.org/2001/XMLSchema#string

David H Barad

http://www.w3.org/2001/XMLSchema#string

Emanuela Lazzaroni

http://www.w3.org/2001/XMLSchema#string

Ho-Joon Lee

http://www.w3.org/2001/XMLSchema#string

Norbert Gleicher

http://www.w3.org/2001/XMLSchema#string

P2860

FMR1 genotype with autoimmunity-associated polycystic ovary-like phenotype and decreased pregnancy chance

Defining ovarian reserve to better understand ovarian aging

Association of FMR1 genotypes with in vitro fertilization (IVF) outcomes based on ethnicity/race

Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function.

Increased oocyte production after treatment with dehydroepiandrosterone.

Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR)

The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment?

Comparison of ovarian FMR1 genotypes and sub-genotypes in oocyte donors and infertile women

Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.

Differences in ovarian aging patterns between races are associated with ovarian genotypes and sub-genotypes of the FMR1 gene.

P2888

s10815-012-9890-z

P304

49-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10815-012-9890-Z

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23212832

http://www.w3.org/2001/XMLSchema#string

P921

P932

3553353

http://www.w3.org/2001/XMLSchema#string